Clinical Trials for Apollomics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Apollomics

Clinical Trials (2)

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

PHASE1/PHASE2Recruiting

27 participants

Started: Jan 18, 2022 · Completed: May 31, 2030

1 condition2 sponsors1 location

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

PHASE2Recruiting

497 participants

Started: Sep 27, 2017 · Completed: Nov 30, 2026

18 conditions1 sponsor35 locations